ClinicalTrials.Veeva

Menu

The Efficacy of Cyanoacrylate Adhesive (PeriAcryl®90 HV) in Periodontal Wound Healing

University of British Columbia logo

University of British Columbia

Status and phase

Unknown
Phase 4

Conditions

Dental Scaling
Oral Surgical Procedures
Tissue Adhesive
Wound Healing
Pain
Periodontal Disease

Treatments

Device: PeriAcryl®90 HV

Study type

Interventional

Funder types

Other

Identifiers

NCT02826109
H15-03277

Details and patient eligibility

About

Periodontal disease is a gum infection caused by plaque on teeth containing both bacteria and calculus (hard) deposits. These need to be removed on a regular basis to maintain gum health and to prevent teeth weakening. A routine cleaning procedure, scaling/root planing, is accompanied with post-operative soft tissue tenderness and teeth sensitivity making oral hygiene maintenance difficult during wound healing. The need for novel therapeutic approaches, such as cyanoacrylate adhesives, has been identified. It has been hypothesized that its application may provide comfort and assist patients with their daily oral self-care procedures following teeth cleaning.

Full description

Hypothesis: The supra-gingival marginal application of cyanoacrylate adhesive will promote periodontal wound healing and prevent the increase of sensitivity of hard (teeth) and soft (gingiva) tissues following non-surgical periodontal therapy (NSPT).

This pilot study involves a small number of participants, and while it is not designed to prove causation, it will evaluate safety and efficacy. If clinical results are positive, these data may be used to determine sample and power needs for larger studies.

With enhanced post-operative comfort, the patient's ability to disrupt biofilm and maintain optimal daily oral self-care can be achieved. Biofilm disruption is paramount to achieving periodontal health. Specifically, the adjunctive placement of an adhesive dressing may reduce biofilm accumulation that is associated with periodontal inflammation. This novel application could improve the patient's oral and thus overall health.

The present pilot trial aims to explore the therapeutic effectiveness of a cyanoacrylate adhesive (PeriAcryl®90 HV) in reducing patient-reported outcomes related to discomfort and sensitivity post NSPT, examine their potential positive effects on periodontal wound healing as well as recording any potential side-effects that may have been experienced by the patients.

Enrollment

20 estimated patients

Sex

All

Ages

19+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

The potential subjects must:

  • Be capable of giving informed consent and 19 years of age or older
  • Have a minimum of 18 teeth and at least 4 measurement sites with pocket depth at least 5.0 mm with bleeding on probing in at least 2 different quadrants
  • Be able to understand and communicate in English, as the study cannot fund a certified interpreter
  • Be willing and able to return for treatment and evaluation throughout the course of this study.

Exclusion criteria

Potential subjects must not:

  • Have had any antibiotics in the last month
  • Be pregnant, nursing or plan to become pregnant over the course of the trial
  • Have an active smoking history (tobacco or otherwise)
  • Have sites with overt abscess, active caries or crown/root fractures
  • Have known adverse reactions or allergies to cyanoacrylates or formaldehyde
  • Have any other significant disease or take medication(s) that, in the opinion of the investigator, may interfere with the evaluation of safety or efficacy of cyanoacrylate and overall compliance.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

Interventional: Cyanoacrylate Application
Experimental group
Description:
Application of cyanoacrylate adhesive to one quadrant of mouth
Treatment:
Device: PeriAcryl®90 HV
Control: Absence of Cyanoacrylate Application
No Intervention group
Description:
No application of cyanoacrylate adhesive to the other quadrant of mouth

Trial contacts and locations

1

Loading...

Central trial contact

Adam Ludlow, BSc (Mol.Bio.; Biochem.); Penny Hatzimanolakis, DipDH, BDSc, MSc, RDH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems